Switch to:
More From Other Websites
Tech and Biotech See Big-Time Insider Buying This Week – Apple, Biogen, Qualcomm and More Aug 01 2015
Biogen’s Experimental Alzheimer Therapy: Limited 2Q15 Success Jul 31 2015
These are the Biggest Risk to Biotech Jul 31 2015
Biogen: Positive 2Q15 Results for Multiple Sclerosis Pipeline Drugs Jul 31 2015
Key for Investors: Why Did Biotech Stocks Fall? Jul 31 2015
​How many multiple sclerosis patients are in the U.S.? No one knows. Jul 30 2015
Biogen Can Get Growth Spurt It Needs With Vertex Deal: Real M&A Jul 30 2015
BIOGEN INC. Financials Jul 30 2015
Biogen: Reports of Its Demise 'Have (Probably!) Been Greatly Exaggerated' Jul 30 2015
Biogen’s Hemophilia Portfolio: Growing Market Share in 2Q15 Jul 30 2015
The Zacks Analyst Blog Highlights: Biogen, AbbVie, Regeneron, Amgen and XOMA - Press Releases Jul 30 2015
Biogen’s Multiple Sclerosis Drugs Show 2Q15 Growth Jul 30 2015
​Sanofi calls out Genzyme, multiple sclerosis drug, as main drivers of growth again Jul 30 2015
​Here are all the Boston-area biotechs about to buy or get bought Jul 29 2015
Biotech Stock Roundup: Biogen Down on Tecfidera Issues, Regeneron's Praluent Gets FDA Nod - Analyst... Jul 29 2015
Four Reasons Gilead Can Head Higher Jul 29 2015
Biogen’s Weak 2Q15 Tecfidera Performance Dampens Sentiment Jul 29 2015
5 Stocks Insiders Love Right Now Jul 29 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK